Mechanisms in endocrinology: The gutbrain axis: regulating energy balance independent of food intake
Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients with Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial
For peptide-based medications like Zepbound, degradation can occur more readily than with small-molecule drugs, making adherence to expiration dates especially critical
This FDA-approved medication does not impose timing restrictions around meals, making it a simpler daily regimen while offering substantial weight loss results
Some people tolerate one medication better than another
About 1020% of patients are non-responders or modest responders